| Stereochemistry | RACEMIC |
| Molecular Formula | C11H17N.ClH |
| Molecular Weight | 199.72 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CNC(C)CC1=CC=C(C)C=C1
InChI
InChIKey=WXLDJVCKXSKYGM-UHFFFAOYSA-N
InChI=1S/C11H17N.ClH/c1-9-4-6-11(7-5-9)8-10(2)12-3;/h4-7,10,12H,8H2,1-3H3;1H
| Molecular Formula | C11H17N |
| Molecular Weight | 163.2594 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
MOL RATIO
1 MOL RATIO (average) |
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
| 207.0 nM [IC50] | |||
| 252.0 nM [IC50] | |||
| 479.0 nM [IC50] |
